Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Alnylam's Yvonne Greenstreet sees a massive pay raise as John Maraganore passes the torch
4 years ago
Pharma
Flagship's Noubar Afeyan recruits the next CEO for one of its stealth biotech startups
4 years ago
'Stuck in the past': Athira hits back at billionaire backer and his bid to put ousted CEO Leen Kawas back in the picture
4 years ago
Scoop: One of Phil Krause’s post-FDA gigs, a biotech trying to develop a Shingrix competitor, goes up for sale
4 years ago
Startups
The bill on Merck's C-suite shakeup includes about $30M for dual CEO pay packages
4 years ago
Pharma
David Sabatini resigns MIT professorship after sexual harassment probe led to ouster from Whitehead Institute
4 years ago
Who are the LGBTQ+ leaders forging paths in biopharma in 2022? Nominate them for an Endpoints special report
4 years ago
R&D
Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies'
4 years ago
Pharma
Cell/Gene Tx
Bluebird joins the layoff flock to reality as gene therapy biotech sheds staff to save itself
4 years ago
R&D
Cell/Gene Tx
'About as true as saying the earth is flat': Alzheimer's expert picks apart Biogen's Aduhelm manuscript
4 years ago
R&D
After steering made-in-China CAR-T all the way from obscurity to approval, Frank Fan resigns from Legend
4 years ago
China
Cell/Gene Tx
Ned Sharpless steps down as head of the National Cancer Institute
4 years ago
FDA+
Middle of the road for CEOs: Bristol Myers' Giovanni Caforio secured almost $20M in 2021 compensation
4 years ago
Pharma
Harvard scientist Charles Lieber seeks acquittal in 'ill-conceived' China Initiative case
4 years ago
China
Law
Seagen CEO Clay Siegall hauls in more than most European counterparts and Moderna's Bancel
4 years ago
Pharma
Inspired by Breaking Bad to make ricin, ex-biotech exec sentenced for lying to FBI
4 years ago
DoJ ‘China Initiative’ probe into stem cell pioneer Haifan Lin discontinued, lawyer says
4 years ago
Taysha joins layoff wave as Dallas biotech pauses most of its R&D work
4 years ago
R&D
Cell/Gene Tx
On a mission to reshape Sanofi, Paul Hudson takes a slight pay cut
4 years ago
Pharma
Roger Perlmutter recruits another Merck vet to his new startup: former CEO Ken Frazier
4 years ago
Peter Thiel's Mithril leads effort to elect a new slate of insiders to the board of troubled Covid player Adagio
4 years ago
Deals
Merck chopping 140-plus staffers out of Acceleron in wake of $11.5B buyout
4 years ago
Pharma
As shares tank, Orchard once again restructures, shedding gene therapy programs and a large part of the staff
4 years ago
Pharma
After failing badly on the new commercialization front, Zealand slashes US staff, sends off CEO and pivots back to R&D
4 years ago
Pharma
First page
Previous page
46
47
48
49
50
51
52
Next page
Last page